ABSTRACT Three distinct classes of human mutations (cbl A, cbl B, and cbl C) cause defective synthesis of cobalamin (Cbl; vitamin B12) coenzymes. Cultured fibroblasts from that unique class (cbl C) deficient in the synthesis of both Cbl coenzymes, 5'-deoxyadenosylcobalamin (AdoCbl) and methylcobalamin (MeCbl), were used to explore the underlying defect. We compared the uptake of transcobalamin II (TC II)-bound cyano by cbl C cells with that of other control and mutant cell lines. Although the cbl C cells initially took up CN4[7CoJCbl normally, they were unable to retain it. To characterize this "leak" further, cell extracts were prepared following incubation and chromatographed on Sephadex G-50. After incubations of 1-2 hr, most of the CN{57CoJCbl accumulated by control cells was still bound to TC II; the remainder was free. Thereafter, an ever-increasing fraction of the labeled Cbl eluted with an intracellular cobalamin-binding protein (ICB) more than 80% of the total was so bound after 76 hr incubations. ICB had an apparent molecular weight similar to that of several Cbl "R" binders (about 120,000), but was distinguished from them by its failure to react with specific anti-"R" binder antiserum. Significantly, no ICB was detected in extracts of three different cbl C lines even after prolonged incubations, whereas its appearance in cbl A, cbl B, and mutase apoenzyme mutants was normal. We propose: that ICB is required for retention of cobalamins by cels; and that cbl C cels "leak" cobalamins and show defective synthesis of Cbl coenzymes because they lack this intracellular binder.
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During the past 15 years a picture of the cellular biology and biochemistry of the compound originally designated vitamin B12 and now more appropriately referred to by its chemical name, cobalamin (Cbl), has begun to emerge. Based on in mvo experiments with radioisotopically labeled Cbl in man (1) (2) (3) , it has been shown that, once absorbed from the small intestine, the vitamin is transported in blood tightly bound to a specific serum protein, transcobalamin II (TC II). The subsequent delivery of Cbl to hepatocytes (3) (4) (5) (6) (7) and other tissue cells (8) (9) (10) (11) (12) (13) ) is mediated by a complicated, still incompletely understood process which is initiated by the binding of the TC II-Cbl complex to specific cell surface receptors. Current evidence favors the belief that the membrane-bound TC II-Cbl complex then enters the cell intact via endocytosis, and is localized transiently in secondary ly- (26) . All cell lines were studied between their 14th and 29th passage in culture, such passages being noted not to affect the ability of cells to take up CN-[57Co]Cbl.
Cell Culture. Fibroblast monolayers were propagated in 75 cm2 plastic flasks (Falcon) at 370 in a 5% C02/95% air atmosphere using Eagle's minimal essential medium supplemented with 10% fetal calf serum (Grand Island Biological), essential amino acids, penicillin (100 units/ml) and streptomycin (0.1 mg/ml). Periodic examination of the cell lines for mycoplasmas was carried out as described previously (25) ; no mycoplasma contamination was found in any of the cell lines used.
Preparation of TC II-Bound CN[57Co]Cbl. Fresh serum from several healthy volunteers was obtained by venesection, pooled, and frozen in aliquots at -20°. For each experiment a thawed aliquot of serum was incubated with CN-
[57Co]Cbl (Amersham/Searle, 90-150 uCi/,gg) at a total concentration of 300 pg/ml for 30 min at 37'. Serum was then dialyzed against 0.01 M KPO4 buffer (pH 8.1) for 15-18 hr. More than 95% of the labeled Cbl was uniformly bound to serum under these conditions; 80-90% of the total being bound to TC II. In later experiments dialysis was omitted because it was found to have no effect on serum binding or fibroblast uptake.
Uptake of TC-II-Bound CN[57Co]Cbl by Monolayers.
Monolayers were prepared for uptake studies by pouring off the growth medium, washing three times with a total of 90 ml of phosphate-buffered saline (pH 7.4) at room temperature, and aspirating any retained buffer. Monolayers were then incubated at 370 for intervals of 1-76 hr in 10 ml of medium identical to that employed for cell propagation except that it now contained 10% human serum to which CN-[57Co]Cbl had been bound. The initial medium concentration of labeled Cbl was 25-30 pg/ml.
Incubations were terminated by decanting the medium, washing the monolayer three times with a total of 90 ml of 0.15 M sodium chloride at 40, and aspirating retained saline. Cells were then removed from the flask by solubilizing them in 1.5 ml of 1% Triton X-100 (New England Nuclear) made up in a 0.15 M sodium chloride, 0.05 M KPO4 buffer (pH 7.4). Alternatively, cells were removed by adding the same volume of Triton-free buffer, harvesting the monolayer by mechanical scraping with a "rubber policeman", sonicating three times (5 sec bursts at 40) in a Branson sonifier, and centrifuging at 48,000 X g for 10 min at 00. Of the 1.5 ml of cell extract so obtained, 1.0 ml was used for gel filtration experiments to be described subsequently. The remainder was used for total protein determination by the fluorescamine method of Udenfriend et al. (27) , or the method of Lowry et al. (28) , and for 57o quantitation in an automatic gamma scintillation spectrometer (Packard). Such studies revealed that about 20% of total monolayer radioactivity was not removed by Triton, and that the gel filtration profiles with the two methods were identical.
Gel Filtration with Sephadex G-150. Columns (1.6 X 100 cm) of Sephadex G-150 (Pharmacia), equilibrated with 0.05 M KPO4 buffer (pH 7.4) containing 1% Triton X-100 and 0.15 M NaCl, were used to chromatograph samples (1.0 ml) of 57Co-containing human serum or fibroblast cell extracts. All experiments were carried out at 40 with gel filtration proceeding in the downward direction at a flow rate of [12] [13] [14] [15] trol and cbl C mutant lines is shown in Fig. 1 (upper frame) . In control lines uptake followed a curvilinear plot with accumulation increasing throughout the 360 min interval studied. Virtually identical curves were obtained when mono- Fig. 2 . When the monolayer was incubated with labeled Cbl for 1 hr (Fig. 2 , left) more than 80% of the 57Co co-chromatographed with TC II; the remainder eluted as free Cbl. By 6 hr, a third peak of radioactivity was apparent which chromatographed between the void volume and TC II. After 12 hr incubations (Fig. 2, center) , TC II-bound and free Cbl were still readily apparent, but nearly 40% of the total cell 57Co now eluted in the third macromolecular peak.
With increasing duration of monolayer incubation, an everlarger fraction of the total cell 57Co appeared with this peak; greater than 80% of the total was so bound by 76 hr of incubation (Fig. 2, right) . Pronase treatment of this peak resulted in complete disappearance of radioactivity from this region of the chromatogram, thereby demonstrating that the 57Co was bound to a Differentiation of ICB from known "R" binders As shown in Fig. 3 , the elution profile of ICB indicated an apparent molecular weight of 120,000, a value very similar to that reported for several Cbl-binding proteins found in serum, granulocytes, saliva, and milk which cross react immunologically and are collectively referred to as "R" binders (29) . To test the thesis that ICB was another "R" binder, we conducted immunochemical experiments using specific, rabbit anti-human "R" binder antiseruml. First, we demonstrated that the expected antigen-antibody reaction would take place in the presence of fibroblast extracts and would be detectable by gel filtration. When 57Co-labeled "R" binder from human saliva was added to a control fibroblast extract, it eluted from Sephadex with an expected apparent molecular weight of about 120,000 (Fig. 4A, solid line) . When anti-"R" binder antiserum was also added before gel filtration, all radioactivity shifted to the void volume, as anticipated for the appearance of a labeled antigen-antibody complex (Fig. 4A, dashed line) . Similar experiments were then carried out with extracts of control fibroblasts incubated for 76 hr with CN-[57Co]Cbl (Fig. 4B) . It is apparent that the addition of a large excess of anti-"R" binder antiserum (dashed line) shifted none of the radioactive material in the ICB peak to the void volume. Such experiments were also performed with anti-TC II antiserum to exclude the unlikely possibility that ICB represented a TC II aggregate. Again, no immunochemical reactivity between the antiserum and ICB was observed.
I The antiserum was prepared against pure "R" binder from human milk and was kindly provided by Dr. Robert Allen, Dept. of Medicine, Washington University School of Medicine, St. Louis, Mo. with its major appearance following incubations of intact cells with TC-II-bound Cbl, suggests that its synthesis or its ability to bind Cbl may require other, still unidentified metabolic events. Third, its failure to react immunochemically with anti-"R" binder antiserum differentiates it from that class of Cbl binder. Fourth, the fact that each of the major intracellular Cbl species (OH-Cbl; MeCbl and AdoCbl) was recovered from the ICB peak after cells were incubated for 72 hr"I raises the possibility that ICB is involved in some way with Cbl interconversion and coenzyme synthesis.
The most dramatic, and potentially most significant, observation relevant to ICB is its absence in three cbl C mutant lines. Since the endogenous total Cbl content of such mutant cells is only 15-25% of that of controls", our failure to detect ICB cannot be ascribed to saturation with unlabeled Cbl. It could also be argued that the appearance of ICB reflects, in some way, mutase activity or Cbl coenzyme synthesis, but this hypothesis is hardly tenable in the face of normal ICB appearance in cbl A and cbl B mutant lines or in those with a mutase apoenzyme defect. Rather, we wish to propose that cbl C mutants are deficient in AdoCbl and MeCbl synthesis because they lack ICB activity. Such lack could result from primary deficiency of ICB or from an abnormality of a metabolic step required for Cbl binding to ICB. We propose further that this deficiency of ICB activity results in the inability of cbl C mutant cells to retain the Cbls which they accumulate, thereby leading to the exaggerated efflux of CN-
[57Co]Cbl observed in our experiments and to the reduced endogenous Cbl content noted in many tissues of these patients (20) (21) (22) (23) .
